MoneyWorks4Me

Suven Pharmaceuticals informs about disclosures

19 Jun 2024 Evaluate
Suven Pharmaceuticals has informed that the Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June 18, 2024 for Berhyanda & Berhyanda Midco.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..